eXoZymes Stock (NASDAQ:EXOZ)

Financials Chart

Previous Close

$11.75

52W Range

$8.50 - $23.99

50D Avg

$14.51

200D Avg

$14.37

Market Cap

$93.05M

Avg Vol (3M)

$15.08K

Beta

3.75

Div Yield

-

EXOZ Company Profile

eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

31

IPO Date

Nov 13, 2024

Website

EXOZ Performance

EXOZ Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-5.93M	$-1.80M	$-1.33M
Net Income	$-5.86M	$-2.04M	$-1.40M
EBITDA	$-5.66M	$-1.60M	$-1.18M
Basic EPS	-	$-0.25	$-0.17
Diluted EPS	-	$-0.25	$-0.17

Fiscal year ends in Dec 24 | Currency in USD